Publication | Open Access
A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine
79
Citations
26
References
2014
Year
VaccinationMucosal VaccinationNovel Tlr2 AgonistVaccine DevelopmentBordetella PertussisMedicineVaccine TargetImmunologyT Cell ImmunityAcellular Pertussis VaccineInnate ImmunityVaccine DesignImmunotherapyPrecision Vaccinology
| Year | Citations | |
|---|---|---|
Page 1
Page 1